It can process upto 8 samples in a single run and ideal for detecting several diseases, including tuberculosis, HPV, 3H (HIV, HCV & HBV), tropical fever & respiratory ailments
Genes2Me has announced the launch of its Rapi-Q- Point of Care RT PCR solution for 1-8 samples. Backed by a software analysis function, this CE-IVD marked POC solution delivers superior performance, high sensitivity, and stable detection.
Rapi-Q point of care RT PCR has been approved by ICMR. This small, light, and easy-to-carry system can process upto 8 samples in a single run and ideal for detecting several diseases, including tuberculosis, HPV, 3H (HIV, HCV & HBV), tropical fever & respiratory ailments.
Neeraj Gupta, Founder and CEO, Genes2Me said, “Rapi-Q is the choice of care for hospitals, blood banks, health clinics, research laboratories, and airports. Today, large volumes of samples need to be tested in clinical laboratories; thus, it takes a long time for results to be interpreted. The test provides much faster access to accurate test results for several diseases at once, allowing for more rapid clinical decision-making and more-appropriate treatments and interventions. In addition, Rapi-Q can help minimise time-dependent changes in samples which can be caused due to delays in the transport of samples to the clinical laboratory. Also, since it tests up to 8 samples at once and has a long service life, the test is energy-efficient and environmentally friendly.”
Rapi-Q comprises an eight-well block design with four fluorescent channels. It can perform singleplex and multiplex for qualitative/quantitative analysis, melting curve analysis, genotyping, etc. Since it is lightweight (less than 3 kg), it can be easily installed in places of mass testing. It is also compatible with 50+ lyophilised room temperature stable disease detection kits. This system provides automated analysis, interpretation and reports.
- Advertisement -